Microvascular angina: angina that predominantly affects women

키워드

참고문헌 (53)

1. Mieres JH, "Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association", Circulation, 111, pp.682~696 (2005)
2. Sullivan AK, "Chest pain in women:clinical, investigative, and prognostic features", BMJ, 308, pp.883~886 (1994)
3. Task Force Members, "2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology", Eur Heart J, 34, pp.2949~3003 (2013)
4. Kaski JC, "Cardiac syndrome X: clinical characteristics and left ventricular function: longterm follow-up study", J Am Coll Cardiol, 25, pp.807~814 (1995)
5. Panza JA., "Myocardial ischemia and the pains of the heart", N Engl J Med, 346, pp.1934~1935 (2002)
6. Lanza GA., "Cardiac syndrome X: a critical overview and future perspectives", Heart, 93, pp.159~166 (2007)
7. Hochman JS, "Sex, clinical presentation, and outcome in patients with acute coronary syndromes: global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators", N Engl J Med, 341, pp.226~232 (1999)
8. Glaser R, "Benefit of an early invasive management strategy in women with acute coronary syndromes", JAMA, 288, pp.3124~3129 (2002)
9. Krumholz HM, "Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction:is there evidence for a gender bias?", Ann Intern Med, 116, pp.785~790 (1992)
10. Diver DJ, "Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing(from the TIMI-IIIA Trial)", Am J Cardiol, 74, pp.531~537 (1994)
11. Bugiardini R, "Angina with “normal”coronary arteries: a changing philosophy", JAMA, 293, pp.477~484 (2005)
12. Jespersen L, "Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events", Eur Heart J, 33, pp.734~744 (2012)
13. van de Hoef TP, "Impaired coronary autoregulation is associated with long-term fatal events in patients with stable coronary artery disease", Circ Cardiovasc Interv, 6, pp.329~335 (2013)
14. Radico F, "Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests", JACC Cardiovasc Interv, 7, pp.453~463 (2014)
15. Mohri M, "Angina pectoris caused by coronary microvascular spasm", Lancet, 351, pp.1165~1169 (1998)
16. Lanza GA, "Primary coronary microvascular dysfunction:clinical presentation, pathophysiology, and management", Circulation, 121, pp.2317~2325 (2010)
17. Quyyumi AA., "Endothelial function in health and disease:new insights into the genesis of cardiovascular disease", Am J Med, 105(1A), pp.32S~39S (1998)
18. Cannon RO 3rd, "“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries", Am J Cardiol, 61, pp.1338~1343 (1988)
19. Rosen SD, "Central neural contribution to the perception of chest pain in cardiac syndrome X", Heart, 87, pp.513~519 (2002)
20. metaiodobenzylguanidine myocardial scintigraphy, "Circulation", 1997, 821~826
21. Gulli G, "Evidence of parasympathetic impairment in some patients with cardiac syndrome X", Cardiovasc Res, 52, pp.208~216 (2001)
22. Ong P, "High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries:the ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)", J Am Coll Cardiol, 59, pp.655~662 (2012)
23. Pijls NH, "Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses", N Engl J Med, 334, pp.1703~1708 (1996)
24. Tonino PA, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention", N Engl J Med, 360, pp.213~224 (2009)
25. De Bruyne B, "Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease", N Engl J Med, 367, pp.991~1001 (2012)
26. De Bruyne B, "Fractional flow reserve-guided PCI for stable coronary artery disease", N Engl J Med, 371, pp.1208~1217 (2014)
27. Henry PD, "Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediation by a serotonergic mechanism", J Clin Invest, 66, pp.306~313 (1980)
28. Auch-Schwelk W, "Modulation of contractions to ergonovine and methylergonovine by nitric oxide and thromboxane A2 in the human coronary artery", J Cardiovasc Pharmacol, 36, pp.631~639 (2000)
29. Hackett D, "Induction of coronary artery spasm by a direct local action of ergonovine", Circulation, 75, pp.577~582 (1987)
30. Kaufmann PA, "Myocardial blood flow measurement by PET: technical aspects and clinical applications", J Nucl Med, 46, pp.75~88 (2005)
31. Yilmaz A, "Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing", Heart, 96, pp.372~379 (2010)
32. Kalinowski L, "Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux:a novel mechanism for antihypertensive action", Circulation, 107, pp.2747~2752 (2003)
33. Bertrand ME, "Treatment of Prinzmetal’s variant angina: role of medical treatment with nifedipine and surgical coronary revascularization combined with plexectomy", Am J Cardiol, 47, pp.174~178 (1981)
34. Lanza GA, "Management of microvascular angina pectoris", Am J Cardiovasc Drugs, 14, pp.31~40 (2014)
35. Cannon RO 3rd, "Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve", Am J Cardiol, 56, pp.242~246 (1985)
36. Ozcelik F, "Antianginal and anti-ischemic effects of nisoldipine and ramipril in patients with syndrome X", Clin Cardiol, 22, pp.361~365 (1999)
37. Li L, "A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow f low phenomenon at 6-month follow-up", PLoS One, 7, pp.e38851~ (2012)
38. Montorsi P, "Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X", Am J Cardiol, 66, pp.302~307 (1990)
39. Lindqvist M, "Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity", J Hypertens, 25, pp.169~175 (2007)
40. Harrison DG, "The nitrovasodilators: new ideas about old drugs", Circulation, 87, pp.1461~1467 (1993)
41. Lanza GA, "Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X", Am J Cardiol, 84, pp.854~856 (1999)
42. Lamendola P, "Effect of ranolazine on arterial endothelial function in patients with type 2 diabetes mellitus", Atherosclerosis, 226, pp.157~160 (2013)
43. Villano A, "Effects of ivabradine and ranolazine in patients with microvascular angina pectoris", Am J Cardiol, 112, pp.8~13 (2013)
44. Mehta PK, "Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease", JACC Cardiovasc Imaging, 4, pp.514~522 (2011)
45. Kaski JC, "Therapeutic options for the management of patients with cardiac syndrome X", Eur Heart J, 22, pp.283~293 (2001)
46. Hongo M, "Coronary microvascular response to intracoronary administration of nicorandil", Am J Cardiol, 75, pp.246~250 (1995)
47. Chen JW, "Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina", Am J Cardiol, 80, pp.32~38 (1997)
48. Yamabe H, "Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms", Cardiovasc Drugs Ther, 9, pp.755~761 (1995)
49. Nalbantgil S, "Altinti, gbreve, Yilmaz H, Nalbantgil II, Onder R. The effect of trimetazidine in the treatment of microvascular angina", Int J Angiol, 8, pp.40~43 (1999)
50. Leonardo F, "Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance", Cardiologia, 44, pp.1065~1069 (1999)
51. Perez NG, "Phosphodiesterase 5A inhibition induces Na+", H+ exchanger blockade and protection against myocardial infarction, 2007, pp.49, 1095~1103
52. Radovits T, "The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus", Br J Pharmacol, 156, pp.909~919 (2009)
53. Park SJ, "Understanding of chest pain in microvascular disease proved by cardiac magnetic resonance image (UMPIRE): study protocol for a randomized controlled trial", Trials, 15, pp.333~ (2014)

관련 논문AI추천